Autres langues Tempus AI, Inc.

Actions

TEM

US88023B1035

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 15/09/2026			Varia. 5j.	Varia. 1 janv.
68,85 ^USD	+10,67%		+7,09%	+16,60%

15/09	Transcript : Tempus AI, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 08:30 AM
11/09	Tempus AI, Inc. lance une initiative pour constituer le plus grand ensemble de données multimodales de génomes entiers afin de stimuler l'innovation en santé pilotée par l'IA	CI

Autres langues

14/09	AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
11/09	Tempus AI, Inc. Launches Effort To Build The Largest Multimodal Whole-Genome Dataset To Advance AI-Driven Healthcare Innovation
11/09	Tempus AI Building Multimodal Whole-Genome Dataset for AI Research
11/09	Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
09/09	Tempus AI Secures Up To $9.5 Million in US Agency Funding for Cardiology Agent
09/09	Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology
09/09	Q1 Report - Focused Execution Driving Growth
04/09	Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
03/09	Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis Pan-Cancer Strategy
01/09	Afternoon Meeting: La renta fija empaña el inicio de septiembre
01/09	Bonds spoil September's opening
01/09	Analyst recommendations: Duolingo, Robinhood, Adobe, CrowdStrike, Salesforce…
24/08	Tempus AI Receives FDA Clearance For Tempus ECG-PH AI Product Intended To Detect Signs Of Pulmonary Hypertension From Standard ECGs
24/08	Tempus AI Gets FDA Clearance for AI-Enabled Pulmonary Hypertension Detector
24/08	Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
21/08	Tempus AI Insider Sold Shares Worth $2,038,723, According to a Recent SEC Filing
21/08	Tempus AI Insider Sold Shares Worth $6,577,840, According to a Recent SEC Filing
21/08	Tempus AI Insider Sold Shares Worth $2,696,444, According to a Recent SEC Filing
21/08	Tempus AI Insider Sold Shares Worth $1,542,674, According to a Recent SEC Filing
11/08	Tempus AI Insider Sold Shares Worth $1,000,800, According to a Recent SEC Filing
06/08	CellCarta Inc. And Tempus AI, Inc. Enter Strategic Collaboration For CDx Commercialization Lab Network
06/08	Tempus AI Insider Sold Shares Worth $1,100,076, According to a Recent SEC Filing
04/08	Tempus Ai, Inc. Announces Study Results Demonstrating Prism2 Multimodal Slide-Level Pathology Foundation Model Performance
04/08	Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
31/07	Tempus Ai Insider Sold Shares Worth $10,514,914, According to a Recent SEC Filing